MO1 Pill - beige round, 8mm
Pill with imprint MO1 is Beige, Round and has been identified as Montelukast Sodium 10 mg (base). It is supplied by Ajanta Pharma USA Inc.
Montelukast is used in the treatment of Allergic Rhinitis; COPD; Allergies; Asthma, Maintenance; Bronchospasm Prophylaxis and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for MO1
Montelukast Sodium
- Imprint
- MO1
- Strength
- 10 mg (base)
- Color
- Beige
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Leukotriene modifiers
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ajanta Pharma USA Inc.
- National Drug Code (NDC)
- 27241-0018
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
croscarmellose sodium,
hydroxypropyl cellulose,
magnesium stearate,
hypromelloses,
titanium dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "MO1"
More about montelukast
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (561)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: leukotriene modifiers
- Breastfeeding
- En español
Patient resources
- Montelukast drug information
- Montelukast Chewable Tablets
- Montelukast Tablets
- Montelukast Oral Granules
Other brands
Professional resources
- Montelukast monograph
- Montelukast Chewable Tablets (FDA)
- Montelukast Oral Granules (FDA)
- Montelukast Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
